Potential treatment strategy for the rare osimertinib resistant EGFR L718Q mutation.

ABSTRACT:

SUBMITTER: Kawase A 

PROVIDER: S-EPMC8987816 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature